Billionaires Holding OGXI

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 21.3M
    Shares Outstanding

  • 44.9M
    Market Cap

News & Insights

ABOUT

OGXI

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. Its lead drug candidate, Custirsen is in Phase III clinical development for the treatment in men with metastatic castrate-resistant prostate ca...

George Soros' Best-Performing Stocks of 2016 -- so Far

NEWS

Hedge funds hate Apple ... but love Facebook

READ MORE